Back to Search
JEANNY B. ARAGON-CHING M.D.
M.D.
Medical Oncology Physician
NPI: 1376701946IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
0101258348(VA)
Hematology (Internal Medicine) Physician
Internal Medicine — Hematology
Code: 207RH0000X
0101258348(VA)
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
MD037179(DC)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
0101258348(VA)
Education
OTHER
Class of 1997
Research & Publications (17)
Phase I study of oral lenalidomide in patients with refractory metastatic cancer.
PMID 19451403·J Clin Pharmacol·2009
3-trial
Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents.
PMID 19235596·Cancer Invest·2009
3-trial
A double-blind randomized crossover study of oral thalidomide versus placebo for androgen dependent prostate cancer treated with intermittent androgen ablation.
PMID 19167733·J Urol·2009
2-rct
Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapy.
PMID 19228742·Clin Cancer Res·2009
8-other
Final analysis of a phase II trial using sorafenib for metastatic castration-resistant prostate cancer.
PMID 19154507·BJU Int·2009
3-trial
ABCB1 genetic variation influences the toxicity and clinical outcome of patients with androgen-independent prostate cancer treated with docetaxel.
PMID 18628469·Clin Cancer Res·2008
8-other
A phase II clinical trial of sorafenib in androgen-independent prostate cancer.
PMID 18172272·Clin Cancer Res·2008
3-trial
Randomized crossover pharmacokinetic study of solvent-based paclitaxel and nab-paclitaxel.
PMID 18594000·Clin Cancer Res·2008
2-rct
Acute aortic dissection in a hypertensive patient with prostate cancer undergoing chemotherapy containing bevacizumab.
PMID 18607842·Acta Oncol·2008
5-case
Kinetics of serum androgen normalization and factors associated with testosterone reserve after limited androgen deprivation therapy for nonmetastatic prostate cancer.
PMID 18710748·J Urol·2008
3-trial
Osteonecrosis of the jaw and the use of antiangiogenic agents: just an association?
PMID 19088325·Oncologist·2008
8-other
Thalidomide analogues as anticancer drugs.
PMID 17975653·Recent Pat Anticancer Drug Discov·2007
6-review
Lack of prognostic significance of prostate biopsies in metastatic androgen independent prostate cancer.
PMID 17850370·BJU Int·2007
2-rct
Chemotherapy in Androgen-Independent Prostate Cancer (AIPC): What's next after taxane progression?
PMID 17712400·Cancer Ther·2007
8-other
Impact of androgen-deprivation therapy on the immune system: implications for combination therapy of prostate cancer.
PMID 17569623·Front Biosci·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 8081 INNOVATION PARK DR
FAIRFAX, VA 22031 - Phone
- (571) 472-4724
Quick Facts
- NPI
- 1376701946
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 3
- Years in Practice
- 29
- Publications
- 17
Are you this provider?
Claim Your Profile